SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Ausgewählte Publikationen seit 1990

 

Bode U, Lörchner M, Pabst R, Wonigeit K, Overbeck S, Rink L, and Hundrieser J

The superantigen-induced polarization of T cells in rat peripheral lymph nodes is influenced by genetic polymorphisms in the IL-4 and IL-6 gene clusters

Int. Immunol. 2006 (accepted Okt 2006)

 

Deppenmeier S, Bock O, Mengel M, Niemann H, Kues W, Lemme E, Wirth D, Wonigeit K, Kreipe H.

Health status of transgenic pigs expressing the human complement regulatory protein CD59.

Xenotransplantation. 2006 Jul;13(4):345-56.

 

Kues WA, Schwinzer R, Wirth D, Verhoeyen E, Lemme E, Herrmann D, Barg-Kues B, Hauser H, Wonigeit K, Niemann H.

Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double-transgenic pigs.

FASEB J. 2006;20:1200-1202

 

Hundrieser J, Düvel H, Trautewig B, Wonigeit K

NKR-P1B Rezeptoren der Ratte sind polymorph und wirken als Alloantigen

Chirurgisches Forum 2005;34:11-13

 

Lambracht-Washington D, Duvel H, Hanisch L, Dinkel A, Wonigeit K.

RT1.L: a family of MHC class Ib genes of the rat major histocompatibility complex with a distinct promoter structure.

Immunogenetics. 2004 Apr;56(1):28-37

 

Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N, Krieg T, Schmidt RE, Wonigeit K.

Enhanced frequency of a PTPRC (CD45) exon A mutation (77C->G) in systemic sclerosis

Genes and Immunity 2003;4:168-169

 

Dahlke MH, Lauth OS, Jager MD, Roeseler T, Timrott K, Jackobs S, Neipp M, Wonigeit K, Schlitt HJ.

In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody.

Blood 2002;99:3566-3572<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

 

Dulat HJ, Baars W, Wonigeit K, Schwinzer R.

Target cells expressing CD95L are protected from lysis mediated by alloactivated T cells but are killed by resting NK cells.

Transplant Proc 2001, 33: 262-3

 

Jager MD, Tsui T, Timrott K, Aselmann H, Deiwick A, Neipp M, Wonigeit K, Klempnauer J, Schlitt HJ.

MHC class II compatibility between donor bone marrow and secondary organ grafts is required for tolerance based on mixed chimerism.

Transplant Proc 2001, 33: 176

 

Jager MD, Tsui T, Aselmann H, Dahlke MH, Deiwick A, Neipp M, Klempnauer J, Wonigeit K, Schlitt HJ.

Features of tolerance achieved by antigen and a single injection of an anti-CD45 mAb in rats.

Transplant Proc 2001, 33: 142

 

Milicevic NM, Luettig B, Trautwein C, Wustefeld T, Mahler M, Jecker P, Wonigeit K, Westermann J.

Splenectomy of rats selectively reduces lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1 expression on B-cell subsets in blood and lymph nodes.

Blood 2001, 98: 3035-3041

 

Niemann H, Verhoeyen E, Wonigeit K, Lorenz R, Hecker J, Schwinzer R, Hauser H, Kues WA, Halter R, Lemme E, Herrmann D, Winkler M, Wirth D, Paul D.

Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection

Transplantation 2001, 72: 1898-1906

 

Ko S, Jager MD, Tsui TY, Deiwick A, Dinkel A, Rohde F, Dahlke MH, Lauth O, Wonigeit K, Schlitt HJ.

Longterm Allograft Acceptance Induced by Single Dose Anti-Leukocyte Common Antigen (RT7) Antibody in the Rat.

Transplantation 2001, 71: 1124-31

 

Ko S, Dahlke MH, Lauth O, Jager MD, Deiwick A, Dinkel A, Tsui T, Wonigeit K, Schlitt HJ.

Bone marrow aplasia induced by passenger leukocytes from heart allografts

Exp Hematol 2001; 29: 339-344

 

Dulat HJ, von Grumbkow C, Baars W, Schroder N, Wonigeit K, Schwinzer R.

Downregulation of human alloimmune responses by genetically engineered expression of CD95 ligand on stimulatoyr and target cells.

Eur J Immunol 2001 ; 31: 2217-2226

 

Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B.

A point mutation in PTPRC (CD45) is associated with the development of multiple sclerosis

Nature Genetics 2000; 26: 495-499

 

Lambracht-Washington D, Fischer Lindahl K, Wonigeit K.

Promoter structures suggest independent translocations of ancestral rat RT1.A and mouse H2-K class I genes

Immunogenetics 2000; 51: 873-877

 

Rehm A, Rohr A, Seitz C, Wonigeit K, Ziegler A, Uchanska-Ziegler B.

Structurally diverse forms of HLA-B27 molecules are displayed in vivo in a cell type-dependent manner

Human Immunol 2000; 61: 408-418

 

Ko S, Deiwick A, Jager MD, Dinkel A, Rohde F, Fischer R, Tsui TY, Rittmann KL, Wonigeit K, Schlitt HJ.

Functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat

Nature Med 1999; 5: 1292-1297

 

Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C.

Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" brown norway rat: disease suceptibility is determined by MHC and MHC-linked effects on the B cell response

J Immunol 1999; 163: 40-49

 

Bode U, Duda C, Weidner F, Rodriguez-Palmero M, Wonigeit K, Pabst R, Westermann J.

Activated T cells enter rat lymph nodes and Preyer's patches via high endothelial venules: Survival by tissue-induced proliferation and preferential exit of CD8+ T cell progeny

Eur J Immunol 1999; 29: 1487-1495

 

Herrmann T, Hofmann K, Nagel NE, Asmuss A, Hunig T, Wonigeit K.

Differential CD4/CD8 subset specific expression of highly homologous rat Tcrb-V8 family members suggests a role of CDR2 and/or CDR4 (HV4) in MHC class specific thymic selection

Int Immunol 1999; 11: 435-444

 

Lambracht-Washington D, Wonigeit K, Lindahl KF.

Gene order of the RT1.M region of the rat MHC exemplifies inter-species conservation with mouse

Transplant Proc 1999; 31: 1515-1516

 

Ko S, Deiwick A, Dinkel A, Wonigeit K, Schlitt HJ..

Contribution of passenger leukocytes to the induction and maintenance of heart allograft acceptance

Transplant Proc 1999; 31: 158-159

 

Ko S, Deiwick A, Dinkel A, Wonigeit K, Schlitt HJ.

Passenger leukocytes from a heart allograft can induce lethal lymphoid aplasia

Transplant Proc 1999; 31: 139-140

 

Wonigeit K, Washington D, Hundrieser J.

Lessons from rat models on the genetic basis of inter-individual differences in lymphocyte phenotype

Transplant Proc 1998; 30: 2341-2343

 

Kiuchi T, Oldhafer KJ, Schlitt HJ, Nashan B, Deiwick A, Wonigeit K, Ringe B, Tanaka K, Yamaoka Y, Pichlmayr R.

Background and prognostic implications of perireperfusion tissue injuries in human liver transplants

Transplantation 1998; 66: 737-747

 

Ueda M, Hundrieser J, Hisanaga M, Tanaka K, Wonigeit K, Pichlmayr R, Schlitt HJ, Yamaoka Y.

Development of microchimerism in pediatric patients after living-related liver transplantation.

Clin Transplant. 1997; 11: 193-200

 

Lambracht D, Wonigeit K, Howard JC, Fischer Lindahl K.

Markers for interspecies relationship in the RT1 complex

Transplant Proc 1997; 29: 1665-1667

 

Bode U, Wonigeit K, Pabst R, Westermann J.

The fate of activated T cells migrating through the body: rescue from apoptosis in the tissue or origin

Eur J Immunol 1997; 27: 2087-2093

 

Tschernig T, Boeke K, Steinhoff G, Wonigeit K, Pabst R, Westermann J.

The lung as a source and a target organ for T and B lymphocytes

Am J Respir Cell Mol Biol 1997; 17: 414-421

 

Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, Joly E, Butcher GW.

Positive and negative MHC class I recognition by rat NK cells

Immunol Reviews 1997; 155: 91-104

 

Winkler M, Christians U, Baumann J, Gonschior AK, Wonigeit K, Pichlmayr R.

Evaluation of the Pro-Trac Tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of Tacrolimus levels in patients after kidney, heart, and liver transplantation

Therapeutic Drug Monitoring 1996; 18:640-646

 

Naper C, Rolstad B, Wonigeit K, Butcher GW, Vaage JT.

Genes in two MHC class I regions control recognition of a single rat NK cell allodeterminant

Int Immunol 1996; 8: 1779-1785

 

Klonz A, Wonigeit K, Pabst R, Westermann J.

Characteristic composition of leukocyte subpopulations in the marginal pool of the rat blood, quick interaction with the peripheral blood and role of adhesion molecule expression

Scand J Immunol 1996; 44: 461-469

 

Kraus E, Lambracht D, Wonigeit K, Hunig T.

Negative regulation of rat NK cell activity by MHC class-I recognition

Eur J Immunol 1996; 26: 2582-2586

 

Giezeman-Smits KM, Kuppen PJ, Ensink NG, Eggermont AM, Stals F, Wonigeit K, Fleuren GJ.

The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells

Immunobiol 1996; 195: 286-299

 

Nashan B, Schlitt HJ, Schwinzer R, Ringe B, Kuse E, Tusch G, Wonigeit K, Pichlmayr R.

Immunoprophylaxis with a monoclonal anti IL-2 receptor antibody in liver transplanted patients

Transplantation 1996; 61: 546-554

 

Hisanaga M, Hundrieser J, Boker K, Uthoff K, Raddatz G, Wahlers T, Wonigeit K, Pichlmayr R, Schlitt HJ.

Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation

Transplantation 1996; 61: 40-45

 

Wonigeit K, Lambracht D.

RT1.Al and class I genes deleted in the mutant haplotype lm1 share a similar promoter region

Transplant Proc 1995; 27: 1522-1523

 

Lautenschlager I, Nashan B, Schlitt HJ, Ringe B, Wonigeit K, Pichlmayr R.

Early intragraft inflammatory events of liver allografts leading to chronic rejection

Transplant Int 1995; 8: 446-451

 

Bokenkamp A, Offner G, Hoyer PF, Vester U, Wonigeit K, Brodehl J.

Improved absorption of cyclopsorin A from a new microemulsion formulation: implications for dosage and monitoring

Pedriatr. Nephrol. 1995; 6, 196-198

 

Lambracht D, Prokop C, Hedrich HJ, Fischer Lindahl K, Wonigeit K.

Mapping of H2-M homolog and MOG genes in the rat MHC

Immunogenetics 42: 418-421, 1995

 

Kiuchi T, Schlitt HJ, Oldhafer KJ, Nashan B, Ringe B, Kitai T, Tanaka A, Wonigeit K, Yamaoka Y, Pichlmayr R.

Backgrounds of early intragraft immune activation and rejection in liver transplant recipients

Transplantation 1995; 60: 49-55

 

Thude H, Hundrieser J, Wonigeit K, Schwinzer R.

A point mutation in the human CD45 gene associated with defective splicing of exon A

Eur. J. Immunol. 1995; 25: 2101-2106

 

Winkler M, Ringe B, Oldhafer K, Kattner A, Farber L, Maibucher A, Wonigeit K, Pichlmayr R.

Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients

Transplant. Int. 1995; 8: 324-326

 

Wang CR, Lambracht D, Wonigeit K, Howard JC, Lindahl KF.

Rat RT1 orthologs of mouse H2-M class Ib genes

Immunogenetics 1995; 42: 63-67

 

Naper C, Vaage JT, Lambracht D, Lovik G, Butcher GW, Wonigeit K, Rolstad B.

Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control

Eur. J. Immunol. 1995; 25: 1249-1256

 

Lambracht D, Wonigeit K.

Sequence analysis of the promoter regions of the classical class I gene RT1.Al and two other class I genes of the rat MHC

Immunogenetics 1995; 41: 375-379

 

Schlitt HJ, Schafers S, Deiwick A, Eckardt KU, Pietsch T, Ebell W, Nashan B, Ringe B, Wonigeit K, Pichlmayr R.

Extramedullary erythropoiesis in human liver grafts

Hapatology 1995; 21: 689-696

 

Lautenschlager I, Nashan B, Schlitt HJ, Hoshino K, Ringe B, Tillmann HL, Manns M, Wonigeit K, Pichlmayr R.

Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology

Transplantation 1994; 58: 1339-1345

 

Winkler M, Ringe B, Rodeck B, Melter M, Stoll K, Baumann J, Wonigeit K, Pichlmayr R.

The use of plasma levels for FK 506 dosing in liver-grafted patients

Transpl. Int. 1994; 7: 329-333

 

Winkler M, Ringe B, Baumann J, Loss M, Wonigeit K, Pichlmayr R.

Comparison of plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression

Clin. Chem. 1994; 40: 2247-2253

 

Vaage JT, Naper C, Lovik G, Lambracht D, Rehm A, Hedrich HJ, Wonigeit K, Rolstad B.

Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens

J. Exp. Med. 1994; 180: 641-651

 

Torres-Nagel NE, Herrmann T, Giegerich G, Wonigeit K, Hunig T.

Preferential TCR V usage in rat repertoire selection: V8 imparts both positive thymic selection by and alloreactivity to RT1f

Int. Immunol. 1994; 6: 1367-1373

 

Schwinzer R, Siefken R, Franklin RA, Saloga J, Wonigeit K, Gelfand EW.

Human CD45RA+ and CD45R0+ T cells exhibit similar CD3/T cell receptor-mediated transmembrane signaling capacities but differ in response to co-stimulatory signals

Eur. J. Immunol. 1994; 24: 1391-1395

 

Schlitt HJ, Hundrieser J, Hisanaga M, Uthoff K, Karck M, Wahlers T, Wonigeit K, Pichlmayr R.

Patterns of donor-type microchimserism after heart transplantation

The Lancet 1994; 343: 1469-1471

Winkler, M., B. Ringe, U. Christians, K.Fr. Sewing, K. Wonigeit, R. Pichlmayr

Therapeutic drug monitoring in patients under FK 506 immunosuppression

Klin. Lab. 40: 1-6, 1994

 

Vaage JT, Lovik G, Naper C, Hedrich HJ, Wonigeit K, Rolstad B.

NK cell alloreactivity in the rat

II. Predominant role of the RT1.C region in determining target cell susceptibility specificity

Transplant. Proc. 1993; 25: 2802-2803

 

Fangmann J, Schwinzer R, Hedrich HJ, Wonigeit K.

Demonstration of RT6 Expression on a CD3- population of intestinal intraepithelial lymphocytes of athymic nude rats

Transplant. Proc. 1993; 25: 2789-2790

 

Lambracht D, Schulze F, Wonigeit K.

Cloning of the RT1.L gene coding for a low polymorphic class I antigen in the rat

Transplant. Proc. 1993; 25: 2766-2767

 

Wonigeit K, Lambracht D, Kunz H, Gill T 3rd, Hedrich HJ.

Characterization of a new recombinant RT1 haplotype (r37) in BN.1B/Pit rats

Transplant. Proc. 1993; 25:2763-2765

 

Lambracht D, Hedrich HJ, Wonigeit K.

Deletion of major histocompatibility complex class I genes in a new mutant RT1 haplotype (lm3) defined in BN.1LM3/Han rats

Transplant. Proc. 1993; 25: 2756-2758

 

Christians U, Spiekermann K, Bader A, Schottmann R, Linck A, Wonigeit K, Sewing KF, Link H.

Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMT

Bone Marrow Transplant. 1993; 12: 27-33

 

Schumann G, Petersen D, Hoyer PF, Wonigeit K.

Monitoring Cyclosporin A (Ciclosporin, INN) concentrations in whole blood: Evaluation of the EMIT Assay in Comparison with HPLC and RIA

Eur. J. Clin. Chem. Clin. Biochem. 1993; 31: 381-388

 

Heemels MT, Schumacher TN, Wonigeit K, Ploegh HL.

Peptide translocation by variants of the transporter associated with antigen processing

Science1993;  262: 2059-2063

 

Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K.

Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3

Am. J. Pathol. 1993; 142: 481-488

 

Binder A, Hedrich HJ, Wonigeit K, Kirchhoff H.

The Mycoplasma arthritidis infection in congenitally athymic nude rats

J. Exp. Anim. Sci. 1993; 35: 177-185

 

Schlitt HJ, Schwinzer R, Wonigeit K.

Responsiveness for mouse IgG2b antibodies to the human / T-cell receptor/CD3 complex: Evidence for genetic determination and low grade antibody cross-linking not mediated by known Fc receptor

Scand. J. Immunol. 1993; 37, 329-336

 

Schlitt HJ, Kanehiro H, Raddatz G, Steinhoff G, Richter N, Nashan B, Ringe B, Wonigeit K, Pichlmayr R.

Persistence of donor lymphocytes in liver allograft recipients

Transplantation 1993; 56: 1001-1007

 

Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R.

Passenger lymphocytes in human liver allografts and their potential role after transplantation

Transplantation 1993; 56: 951-955

 

Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flad HD, Pichlmayr R.

Production of cytokines (TNF-, IL-1-) and endothelial cell activation in human liver allograft rejection

Transplantation 1993; 55: 329-335

 

Schwinzer R, Schraven B, Kyas U, Meuer SC, Wonigeit K.

Phenotypical and biochemical characterization of a variant CD45R expression pattern in human leukocytes

Eur. J. Immunol. 1992; 22: 1095-1098

 

Schlitt HJ, Nashan B, Krick P, Ringe B, Wittekind C, Wonigeit K, Pichlmayr R.

Intragraft immune events after human liver transplantation

Transplantation 1992; 54: 273-278

 

Schwinzer R, Schlitt HJ, Wonigeit K.

Monoclonal antibodies to common epitopes of the human / T-cell receptor preferentially activate CD45RA+ T-cells

Cell. Immunol. 1992; 140: 31-41

 

Winkler M, Schumann G, Petersen D, Oellerich M, Wonigeit K.

Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart and liver transplantation

Clin. Chem. 1992; 38: 123-126

 

Fangmann J, Schwinzer R, Vogt P, Wonigeit K.

Prolongation of kidney and skin allograft survival in the rat by monoclonal antibody therapy directed to the RT6.1 T-cell alloantigen

Transplant. Proc. 1991; 23: 504-506

 

Wonigeit K, Hanisch L.

Two new class I loci in the rat major histocompatibility complex: RT1.L and RT1.M

Transplant. Proc. 1991; 23: 468-470

 

Christians U, Kohlhaw K, Budniak J, Bleck JS, Schottmann R, Schlitt HJ, Almeida VM, Deters M, Wonigeit K, Pichlmayr R, et al.

Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejection

Eur. J. Clin. Pharmacol. 1991; 41: 291-296

 

Christians U, Kohlhaw K, Budniak J, Bleck JS, Schottmann R, Schlitt HJ, Almeida VM, Deters M, Wonigeit K, Pichlmayr R, et al.

Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity

Eur. J. Clin. Pharmacol. 1991; 42: 285-290

 

Bleck JS, Schlitt HJ, Christians U, Schottmann R, Thiesemann C, Strohmeyer S, Kohlhaw K, Wonigeit K, Pichlmayr R, Sewing KF.

Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function.

Eur. J. Clin. Pharmacol. 1991; 40: 565-569

 

Schwinzer R, Sommermeyer H, Schlitt HJ, Schmidt RE, Wonigeit K.

Activation of human thymocytes by antibodies to the CD3/T-cell receptor complex: triggering of different epitopes results in different signals

Cell. Immunol. 1991; 136: 318-328

 

Fangmann J, Schwinzer R, Wonigeit K.

Unusual phenotype of intestinal intraepithelial lymphocytes in the rat: predominance of T cell receptor /+CD2- cells and high expression of RT6 alloantigen

Eur. J. Immunol. 1991; 21: 753-760

 

Schlitt HJ, Nashan B, Ringe B, Bunzendahl H, Wittekind C, Wonigeit K, Pichlmayr R.

Differentiation of liver graft dysfunction by transplant aspiration cytology

Transplantation 1991; 51: 786-792

 

Schlitt HJ, Christians U, Bleck J, Kohlhaw K, Ringe B, Bunzendahl H, Sewing KF, Wonigeit K, Pichlmayr R..

Contribution oy cyclosporin metabolites in livertransplanted patients with severe graft dysfunction

Transplant. Int. 1991; 4: 38-44

 

Wonigeit K.

A new dwarf rat strain derived from a subline of BB/W rats

Transplant. Proc. 1990; 22: 2577-2578

 

Hedrich HJ, Fangmann J, Reetz IC, Kloting I, Kornerup Hansen A, Wonigeit K.

Genetic characterization of different diabetes-prone and -resistant BB-rat strains with special reference to RT6

Transplant. Proc. 1990; 22: 2570-2571

 

Schulze F, Winkler M, Schwinzer R, Wonigeit K.

Expression of RT1.C antigens on lymphoid cells: analysis by monoclonal antibodies

Transplant. Proc. 1990; 22: 2514-2516

 

Lambracht D, Hanisch L, Wurst W, Gunther E, Wonigeit K.

Restriction fragment-length polymorphism analysis of a second laboratory-derived mutant RT1 haplotype

Transplant. Proc.1990;  22: 2512-2513

 

Wonigeit K, Kohlhaw K, Winkler M, Schaefer O, Pichlmayr R.

Cyclosporine monitoring in liver allograft recipients: Two distinct patterns of blood level derangement associated with nephrotoxicity

Transplant. Proc. 1990; 22: 1305-1311

 

Sewing KF, Christians U, Kohlhaw K, Radeke H, Strohmeyer S, Kownatzki R, Budniak J, Schottmann R, Bleck JS, Almeida VM, et al.

Biologic activity of Cyclosporine metabolites

Transplant. Proc. 22: 1129-1134, 1990

 

Steinhoff G, Behrend M, Wonigeit K.

Expression of adhesion melecules on lymhocytes/monocytes and hepatocytes in human liver grafts

Human Immunol. 1990; 28: 123-127

 

Schlitt HJ, Schwinzer R, Wonigeit K.

Different activation states of human lymphocytes after antibody-mediated stimulation via CD3 and the /-T cell receptor

Scand. J. Immunol. 1990; 32: 717-726

 

Bleck JS, Nashan B, Christians U, Schottmann R, Wonigeit K, Sewing KF.

Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsule

Arzneim.-Forsch./Drug Res. 1990; 40: 62-64

 

Kietzmann M, Lubach D, Wonigeit K.

Influence of Ciclosporin on epidermal proliferation after mechanical skin irritation

Pharmacology 1990; 40: 122-128

 

Schwinzer R, Wonigeit K.

Genetically determined lack of CD45R- T cells in healthy individuals. Evidence for a regulatory polymorphism of CD45R antigen expression

J. Exp. Med. 1990; 171: 1803-1808<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />